1 Incredibly Cheap Weed Stock You Can Buy Now

The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) is making great strides to dominate the organic cannabis market. Investors should consider taking a position on the weed stock that is trading at a very cheap price.

Cannabis 2.0
You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

An interesting investment option you should consider in the cannabis space is The Green Organic Dutchman (TSX:TGOD) or TGOD.

The company is the only cannabis producer to be certified organic — the key factor in propelling the stock. You should take advantage of the weed stock’s incredibly low price.

Latest developments

TGOD has jumped on the bandwagon of Canadian cannabis companies listing on U.S. exchanges.

Last week, the company applied to list on the NASDAQ — a move intended to attract the big institutional funders and broaden TGOD’s investor base.

The NASDAQ application follows Health Canada’s renewal of the company’s Ancaster facility licence to cultivate, process, and sell cannabis.

The licence is valid until August 2022. TGOD’s planned capacity is 219,000 kilograms. and the state-of-the-art hybrid greenhouse in Ancaster would add 17,500 kilograms.

As well as its cultivation licence, TGOD is hoping to secure an eGMP certification for the export of organic cannabis products. Part of the vision is to be the premium global organic cannabis company.

Growth initiatives

The operations in Canada, Europe, Latin America, and the Caribbean are focused more on medical cannabis, but TGOD is also aiming for a share of the domestic adult-use market.

Organic hemp is another growth driver. TGOD has organic hemp CBD oil operations in Canada. Its subsidiary, HemPoland will distribute premium hemp CBD oil in EU markets.

TGOD has also signed a three-year supply agreement with another cannabis company, Neptune Wellness, to which it will supply about 230,000 kilograms of cannabis and hemp biomass.

Neptune will extract and purify cannabinoids and terpenes and convert them into organic finished products.

From a holistic viewpoint, the business outlook is bright. With all the tailwinds, TGOD can deliver explosive growth in the near term and achieve robust financial health over time.

The company also doesn’t have any substantial debt obligations to worry about. There’s legroom to borrow or raise debt if necessary.

The vision

TGOD wants to differentiate itself from other cannabis producers. The company’s organic process uses synthetic-free fertilizers and pesticides to produce cleaner products. Conscientious customers are willing to pay a premium for certified organic cannabis.

Canada’s largest licensed producer of 100% certified organic cannabis flowers and oils is starting to execute its business plan and create value for shareholders.

TGOD is sure to grow certified organic cannabis at scale and become the leading global organic cannabis brand.

With its staggering revenue-generating potential, TGOD is the most undervalued weed stock. Analysts expect to see the current price of $3.44 increasing by as much as 160% when TGOD aligns with its fundamentals.

However, the forecasts could change after the release of the company’s second-quarter 2019 earnings report on August 13.

TGOD finished the first quarter with a strong balance sheet and with $224.4 million in cash that will be used for expansion and international growth. Investors want to see better financial results.

Nonetheless, if you’re looking for a weed stock with great value and a strong upside, TGOD is the one.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »